Described herein are pharmaceutical packaging units which stop oxidative degradation of morphine, hydromorphone, promethazine as well as other oxygen-delicate drugs, such systems which include a syringe with the oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging with extremely very low permeability to oxygen and